Immune to Cancer: The CRI Blog
-
CICON24 Recap: Key Breakthroughs and Bold Conversations Shaping the Future of Immunotherapy
The Cancer Immunotherapy Conference (CICON24) opened with a palpable sense of urgency and optimism, bringing together the… -
National Hispanic Heritage Month: Honoring Contributions in Immunotherapy
Immunotherapy is a personalized, powerful, and predictable treatment that holds immense progress and potential against cancer. This… -
Ovarian Cancer Awareness Month: How Immunotherapy Fights This High-Occurrence Malignancy
Ovarian cancer is one of several gynecologic malignancies, impacting about 300,000 women globally each year. September has… -
Prostate Cancer Awareness Month: Unlocking the Power of Immunotherapy to Combat a Common Men’s Cancer
Prostate cancer is the second most common for men, only trailing skin cancer. Approximately 1.3 million men… -
Key Discoveries from the AMADEUS Clinical Trial on Cancer Treatment
The Cancer Research Institute (CRI) is excited to share the findings from the AMADEUS clinical trial, which… -
How Immunotherapy Before Surgery Can Impact Patient Outcomes
For some cancer patients, immunotherapy can serve as a first-line treatment, while for others it can act… -
How CAR T Cell Therapy is Pushing the Boundaries of Cancer Treatment
Adoptive cellular therapy is a branch of immunotherapy that channels the body’s cancer-fighting cells to eliminate the…